Journal of the American Academy of Dermatology · 2018
Guidelines of care for the management of basal cell carcinoma.
СтатьяКлинические рекомендацииНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Work Group, Invited Reviewers, Kim John Y S, Kozlow Jeffrey H, Mittal Bharat, Moyer Jeffrey, Olencki Thomas, Rodgers Phillip
Аннотация
Basal cell carcinoma (BCC) is the most common form of human cancer, with a continually increasing annual incidence in the United States. When diagnosed early, the majority of BCCs are readily treated with office-based therapy, which is highly curative. In these evidence-based guidelines of care, we provide recommendations for the management of patients with BCC, as well as an in-depth review of the best available literature in support of these recommendations. We discuss biopsy techniques for a clinically suspicious lesion and offer recommendations for the histopathologic interpretation of BCC. In the absence of a formal staging system, the best available stratification based on risk for recurrence is reviewed. With regard to treatment, we provide recommendations on treatment modalities along a broad therapeutic spectrum, ranging from topical agents and superficially destructive modalities to surgical techniques and systemic therapy. Finally, we review the available literature and provide recommendations on prevention and the most appropriate follow-up for patients in whom BCC has been diagnosed.
Предметные рубрики MeSH
Administration, CutaneousAminoquinolinesAnilidesAntineoplastic AgentsBasal Cell CarcinomaDermatologic Surgical ProceduresEarly Detection of CancerHumansImiquimodNeoplasm GradingNeoplasm StagingNeoplasms, Second PrimaryPhotochemotherapyPhotosensitizing AgentsPyridinesRadiotherapySkin NeoplasmsUnited States